# Bordetella Pertussis Colonisation Challenge Study

> **NCT03751514** · NA · UNKNOWN · sponsor: **University of Southampton** · enrollment: 80 (estimated)

## Conditions studied

- Whooping Cough

## Interventions

- **BIOLOGICAL:** Bordetella Pertussis B1917
- **DRUG:** Azithromycin 500 mg
- **OTHER:** Sterile Saline

## Key facts

- **NCT ID:** NCT03751514
- **Lead sponsor:** University of Southampton
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-22
- **Primary completion:** 2021-02-02
- **Final completion:** 2021-02-02
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2020-02-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03751514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03751514, "Bordetella Pertussis Colonisation Challenge Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03751514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*